A practical reference on HPLC-UV: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-13 and is reviewed periodically as new material appears.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
== Pelvic diaphragm == The muscular pelvic diaphragm is composed of the bilateral levator ani and coccygeus muscles and these attach to the inner pelvic surface. The iliococcygeus and pubococcygeus make up the levator ani muscle. The muscles pass behind the rectum. The levator ani surrounds the opening which the urethra, rectum and vagina pass. The pubococcygeus muscle is subdivided into the pubourethralis, pubovaginal muscle and the puborectalis muscle. The names describe the attachments of the muscles to the urethra, vagina, anus, and rectum. The names are also called the pubourethralis, pubovaginalis, puboanalis, and puborectalis muscles and sometimes the pubovisceralis since it attaches to the viscera.
Individual variation within any racial group spans over 7 cm (3 inches) in some datasets, a range that is 15 to 30 times greater than the alleged average differences between racial groups, which typically measure less than 0.5 cm (0.2 inches) in clinician-measured studies. Factually race is therefore a poor predictor of any individual's penis size, and reported racial averages do not account for the substantial overlap between group distributions.
In bodybuilding and weight training, using drop sets (a.k.a. dropsets, descending sets, strip sets, the multi-poundage system the stripping method, triple-drops, down the rack, or running the rack) is a technique for continuing an exercise with a lower weight once muscle failure has been achieved at a higher weight. It is most often performed on weight machines because the weight is easier to switch, but it can also be performed with dumbbells and other free weights.
== Aim == Green nanotechnology has two goals: producing nanomaterials and products without harming the environment or human health, and producing nano-products that provide solutions to environmental problems. It uses existing principles of green chemistry and green engineering to make nanomaterials and nano-products without toxic ingredients, at low temperatures using less energy and renewable inputs wherever possible, and using lifecycle thinking in all design and engineering stages. In addition to making nanomaterials and products with less impact to the environment, green nanotechnology also means using nanotechnology to make current manufacturing processes for non-nano materials and products more environmentally friendly. For example, nanoscale membranes can help separate desired chemical reaction products from waste materials from plants. Nanoscale catalysts can make chemical reactions more efficient and less wasteful. Sensors at the nanoscale can form a part of process control systems, working with nano-enabled information systems. Using alternative energy systems, made possible by nanotechnology, is another way to "green" manufacturing processes. The second goal of green nanotechnology involves developing products that benefit the environment either directly or indirectly. Nanomaterials or products directly can clean hazardous waste sites, desalinate water, treat pollutants, or sense and monitor environmental pollutants.
Sources: en.wikipedia.org
=== Production during the Manhattan Project === During World War II the U.S. government established the Manhattan Project, for developing an atomic bomb. The three primary research and production sites of the project were the plutonium production facility at what is now the Hanford Site, the uranium enrichment facilities at Oak Ridge, Tennessee, and the weapons research and design lab, now known as Los Alamos National Laboratory, LANL.
== Safety == Hormone therapy for transgender individuals has been shown in medical literature to be generally safe, when supervised by a qualified medical professional. There are potential risks with hormone treatment that will be monitored through screenings and lab tests such as blood count (hemoglobin), kidney and liver function, blood sugar, potassium, and cholesterol. Taking more medication than directed may lead to health problems such as increased risk of cancer, heart attack from thickening of the blood, blood clots, and elevated cholesterol. Hormone therapy has been shown to improve the psychosocial well-being, and lower levels of distress among transgender individuals. Cardiovascular risks vary by hormone regimen, dose, route of administration, age, smoking status, and other individual risk factors. Estrogen therapy is associated with concern about venous thromboembolism, while testosterone therapy may affect cardiovascular risk factors such as blood pressure, lipids, weight, and erythrocytosis. A 2025 Dutch cohort study found that cardiovascular risk patterns differed between transgender women and transgender men receiving gender-affirming hormone therapy: transgender women did not have increased arterial cardiovascular risk compared with general-population men, but had increased venous thromboembolism risk, while transgender men had increased risks of myocardial infarction and ischaemic cerebrovascular accident compared with general-population women.
Negros is noted for being the nation's prime producer and exporter of sugar. Sugarcane plantations abound in the agricultural areas of the island. The island also produces cotton and hardwood. Sugar is the biggest industry in the island, followed by organic agricultural products and gamefowl breeding. Its principal sugar-growing region is located in the north and west of the island, stretching from northwest along the coasts of the Visayan Sea and Guimaras Strait, which is one of the nation's principal lowland areas in the Visayas. Negros is now aiming to be the prime producer of organic agricultural produce in Asia. Sugar refining has many by-products such as acetylene, fertilizers and rum. Fishing is the major industry based in Cadiz. There are also a number of fishponds and prawn farming has become a major industry. Bacolod City is the center of commerce and finance in Negros. It is where oil companies, factories, bottling plants, allied industrial businesses, steel fabrication, power generation, agri-businesses, prawn culture and other aqua-culture ventures are found. By November 2016, Negros generated a total net worth of ₱14.355 billion, placing its provinces among the richest in the country.
Pedanius Dioscorides (De Materia Medica), a Greek physician living in Rome during the first century A.D., who is recorded as the first person to make explicit reference to the administration of mandrake-induced anesthesia to facilitate a surgical intervention. Galen Hippocrates Theophrastus (Historia Plantarum)
==== Confrontations with students ==== Student protests of 1968 took place in West Germany during the same period as the publication of Negative Dialectics'. Trends in the media, an educational crisis in the universities, the Shah of Iran's 1967 state visit, German support for the war in Vietnam, and the emergency laws combined to create a highly unstable situation. Like many of his students, Adorno too opposed the emergency laws, as well as the war in Vietnam, which, he said, proved the continued existence of the "world of torture that had begun in Auschwitz." The situation only deteriorated with the police shooting of Benno Ohnesorg at a protest against the Shah's visit. This death, as well as the subsequent acquittal of the responsible officer, were both commented upon in Adorno's lectures. As politicization increased, rifts developed within both the Institute's relationship with its students as well as within the Institute itself. Soon, Adorno himself would become an object of the students' ire. At the invitation of Péter Szondi, Adorno was invited to the Free University of Berlin to give a lecture on Goethe's Iphigenie in Tauris. After a group of students marched to the lectern, unfurling a banner that read "Berlin's left-wing fascists greet Teddy the Classicist," a number of those present left the lecture in protest after Adorno refused to abandon his talk in favor of discussing his attitude on the current political situation.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.